Interactive Session on Psychedelics for Alcoholism, Q&A with Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) Management
Clearmind (CSE: CMND) (FSE: CWY0) Management invites leaders, innovators, scientists, doctors, patients, enthusiasts, and luminaries in the psychedelic space to attend a virtual Q&A session on March 30th, focused on the potential treatment of alcohol use and binge drinking based on its psychoactive molecule MEAI. Global leaders and innovators in the psychedelic space will participate in the virtual event and discuss psychedelic therapies and treatments for excessive alcohol consumption and mental disorders. The dedicated team of experts at Clearmind is engaged in developing breakthrough treatments for binge behaviour, alcohol use disorder, binge eating and depression. Adi Zuloff-Shani, PhD, Clearmind’s Chief…